Trial Profile
Effect of Aflibercept Therapy on Subfoveal Choroidal Thickness in Patients with Neovascular Age-Related Macular Degeneration.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Sep 2016
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary)
- Indications Wet age-related macular degeneration
- Focus Pharmacodynamics
- 15 Sep 2016 New trial record